ID

16812

Descripción

Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00156975

Link

https://clinicaltrials.gov/show/NCT00156975

Palabras clave

  1. 8/8/16 8/8/16 -
  2. 8/8/16 8/8/16 -
Subido en

8 de agosto de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Neoplasms NCT00156975

Eligibility Colorectal Neoplasms NCT00156975

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients after r0-resection of colorectal liver metastases
Descripción

Colorectal Carcinoma Excision | Secondary malignant neoplasm of liver Excision | Residual tumor stage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C0728940
UMLS CUI [2,1]
C0494165
UMLS CUI [2,2]
C0728940
UMLS CUI [3]
C0475286
age: >= 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky-index >= 70%
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
neutrophiles >1,5 x10e9/l, thrombocytes 100 x10e9/l
Descripción

Absolute neutrophil count | Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
adequate contraception for male and female patients
Descripción

Gender Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
oral and written informed consent (gcp)
Descripción

Informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
other prior malignancies, except treated in situ-carcinoma of cervix or tumours of skin without indication to a melanoma (or 10 years tumourfree)
Descripción

Malignant Neoplasms | Carcinoma in situ of uterine cervix Treated | Skin carcinoma Treated | Malignant Neoplasm Free Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0851140
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0699893
UMLS CUI [3,2]
C1522326
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C0332296
UMLS CUI [4,3]
C1265611
other participation in clinical trials within 30 days before randomization
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
previous chemotherapy (except adjuvant chemotherapy with an interval of >= 6 months)
Descripción

Prior Chemotherapy | Chemotherapy, Adjuvant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0085533
creatinine clearance <50 ml/min
Descripción

Creatinine clearance measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
hepatic insufficiency (alat, asat, bilirubin, ap >5 x upper limit)
Descripción

Hepatic Insufficiency | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement | Alkaline Phosphatase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1306571
UMLS CUI [2]
C0201836
UMLS CUI [3]
C0201899
UMLS CUI [4]
C1278039
UMLS CUI [5]
C0002059
peripheral neuropathy > ctc grade 1
Descripción

Peripheral Neuropathy | CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
uncontrolled cardiac insufficiency or angina pectoris
Descripción

Heart failure Uncontrolled | Angina Pectoris Uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018801
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0002962
UMLS CUI [2,2]
C0205318
active infections
Descripción

Communicable Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
severe neurological or psychiatric illness
Descripción

nervous system disorder Severe | Mental disorder Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027765
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0004936
UMLS CUI [2,2]
C0205082
breast-feeding or pregnant women
Descripción

Breast Feeding | Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2]
C0032961
incapacity to take part in regular visits
Descripción

Patient Visit Regular participation Impairment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512346
UMLS CUI [1,2]
C0205272
UMLS CUI [1,3]
C0679823
UMLS CUI [1,4]
C0221099

Similar models

Eligibility Colorectal Neoplasms NCT00156975

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma Excision | Secondary malignant neoplasm of liver Excision | Residual tumor stage
Item
patients after r0-resection of colorectal liver metastases
boolean
C0009402 (UMLS CUI [1,1])
C0728940 (UMLS CUI [1,2])
C0494165 (UMLS CUI [2,1])
C0728940 (UMLS CUI [2,2])
C0475286 (UMLS CUI [3])
Age
Item
age: >= 18 years
boolean
C0001779 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky-index >= 70%
boolean
C0206065 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement
Item
neutrophiles >1,5 x10e9/l, thrombocytes 100 x10e9/l
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Gender Contraceptive methods
Item
adequate contraception for male and female patients
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed consent
Item
oral and written informed consent (gcp)
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Carcinoma in situ of uterine cervix Treated | Skin carcinoma Treated | Malignant Neoplasm Free Quantity
Item
other prior malignancies, except treated in situ-carcinoma of cervix or tumours of skin without indication to a melanoma (or 10 years tumourfree)
boolean
C0006826 (UMLS CUI [1])
C0851140 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0699893 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0006826 (UMLS CUI [4,1])
C0332296 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
Study Subject Participation Status
Item
other participation in clinical trials within 30 days before randomization
boolean
C2348568 (UMLS CUI [1])
Prior Chemotherapy | Chemotherapy, Adjuvant
Item
previous chemotherapy (except adjuvant chemotherapy with an interval of >= 6 months)
boolean
C1514457 (UMLS CUI [1])
C0085533 (UMLS CUI [2])
Creatinine clearance measurement
Item
creatinine clearance <50 ml/min
boolean
C0373595 (UMLS CUI [1])
Hepatic Insufficiency | Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Serum total bilirubin measurement | Alkaline Phosphatase
Item
hepatic insufficiency (alat, asat, bilirubin, ap >5 x upper limit)
boolean
C1306571 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C1278039 (UMLS CUI [4])
C0002059 (UMLS CUI [5])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy > ctc grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Heart failure Uncontrolled | Angina Pectoris Uncontrolled
Item
uncontrolled cardiac insufficiency or angina pectoris
boolean
C0018801 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0002962 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Communicable Diseases
Item
active infections
boolean
C0009450 (UMLS CUI [1])
nervous system disorder Severe | Mental disorder Severe
Item
severe neurological or psychiatric illness
boolean
C0027765 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0004936 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Breast Feeding | Pregnancy
Item
breast-feeding or pregnant women
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
Patient Visit Regular participation Impairment
Item
incapacity to take part in regular visits
boolean
C1512346 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0679823 (UMLS CUI [1,3])
C0221099 (UMLS CUI [1,4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial